Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01541969

Evaluation of the CR Neuromodulation Treatment for Tinnitus (RESET2)

Systematic Evaluation of the Acoustic CR ® Neuromodulation Treatment for Tinnitus

Sponsor: Nottingham University Hospitals NHS Trust

Conditions Tinnitus

Interventions CR Neuromodulation Tinnitus masking

Updated 6 times since 2017 Last updated: Jul 21, 2016 Started: Aug 31, 2012 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01541969, this PHASE2/PHASE3 trial focuses on Tinnitus and remains completed. Sponsored by Nottingham University Hospitals NHS Trust, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nottingham University Hospitals NHS Trust
University College, London
University of Nottingham

Data source: Nottingham University Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom
• Nottingham, United Kingdom